🌎 Progyny Downgraded, 3M Upgraded, Lear Upgraded and more…
RJ Hamster
Advertisements
Ratings changes for Applied Optoelectronics, Warner Bros. Discovery, Amicus Therapeutics, Applied Optoelectronics, MKS Instruments, Progyny, Minerva Neurosciences and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
Bitcoin has surged past $70,000. Are you prepared for what’s next? Our free guide, “Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024,” is essential for staying ahead in the fast-evolving crypto market. It’s crafted for both beginners and seasoned investors. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.
Apple Inc. (NASDAQ:AAPL) announced a quarterly dividend on Thursday, May 2nd. Stockholders of record on Monday, May 13th will be given a dividend of 0.25 per share by the iPhone maker on Thursday, May 16th. This represents a $1.00 annualized dividend and a dividend yield of 0.55%. The ex-dividend date is Friday, May 10th. This is an increase from Apple’s previous quarterly dividend of $0.24.
Amazon.com was the recipient of unusually large options trading on Thursday. Stock traders purchased 676,766 call options on the stock. This represents an increase of approximately 27% compared to the typical volume of 533,724 call options.
insider Jennifer Newstead sold 576 shares of Meta Platforms stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $466.33, for a total transaction of $268,606.08. Following the completion of the sale, the insider now owns 36,067 shares of the company’s stock, valued at $16,819,124.11. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Array Technologies (NASDAQ:ARRY) was upgraded by analysts at Oppenheimer Holdings Inc. from a “market perform” rating to an “outperform” rating. They now have a $20.00 price target on the stock. This represents a 57.6% upside from the current price of $12.69.
Bumble (NASDAQ:BMBL) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $14.00 price target on the stock. This represents a 24.0% upside from the current price of $11.29.
Dutch Bros (NYSE:BROS) was upgraded by analysts at TD Cowen from a “hold” rating to a “buy” rating. They now have a $46.00 price target on the stock, up previously from $33.00. This represents a 29.3% upside from the current price of $35.57.
Cheesecake Factory (NASDAQ:CAKE) was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $47.00 price target on the stock, up previously from $38.00. This represents a 26.1% upside from the current price of $37.27.
Dominion Energy (NYSE:D) was upgraded by analysts at Bank of America Co. from an “underperform” rating to a “neutral” rating. They now have a $54.00 price target on the stock, up previously from $43.00. This represents a 1.3% upside from the current price of $53.31.
HBT Financial (NASDAQ:HBT) was upgraded by analysts at Raymond James from a “market perform” rating to an “outperform” rating. They now have a $23.00 price target on the stock. This represents a 17.7% upside from the current price of $19.54.
Lear (NYSE:LEA) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $160.00 price target on the stock, up previously from $150.00. This represents a 22.7% upside from the current price of $130.35.
3M (NYSE:MMM) was upgraded by analysts at HSBC Holdings plc from a “hold” rating to a “buy” rating. They now have a $115.00 price target on the stock, up previously from $91.13. This represents a 15.8% upside from the current price of $99.29.
Novavax (NASDAQ:NVAX) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating.The current price is $9.06.
Roblox (NYSE:RBLX) was upgraded by analysts at Moffett Nathanson from a “sell” rating to a “neutral” rating. They now have a $26.00 price target on the stock. This represents a 18.0% downside from the current price of $31.71.
Relay Therapeutics (NASDAQ:RLAY) was upgraded by analysts at Barclays PLC from an “equal weight” rating to an “overweight” rating. They now have a $15.00 price target on the stock. This represents a 139.6% upside from the current price of $6.26.
Squarespace (NYSE:SQSP) was upgraded by analysts at Mizuho from a “neutral” rating to a “buy” rating. They now have a $50.00 price target on the stock, up previously from $34.00. This represents a 32.1% upside from the current price of $37.84.
TPG (NASDAQ:TPG) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $52.00 price target on the stock, up previously from $43.00. This represents a 19.9% upside from the current price of $43.38.
Tower Semiconductor (NASDAQ:TSEM) was upgraded by analysts at Susquehanna from a “neutral” rating to a “positive” rating. They now have a $55.00 price target on the stock, up previously from $36.00. This represents a 50.8% upside from the current price of $36.48.
Warner Bros. Discovery (NASDAQ:WBD) was upgraded by analysts at KeyCorp from a “sector weight” rating to an “overweight” rating. They now have a $11.00 price target on the stock. This represents a 35.3% upside from the current price of $8.13.
Baxter International (NYSE:BAX) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $40.00 price target on the stock. This represents a 12.2% upside from the current price of $35.64.
Collegium Pharmaceutical (NASDAQ:COLL) was downgraded by analysts at Piper Sandler from an “overweight” rating to a “neutral” rating. They now have a $39.00 price target on the stock. This represents a 23.0% upside from the current price of $31.72.
Collegium Pharmaceutical (NASDAQ:COLL) was downgraded by analysts at Needham & Company LLC from a “buy” rating to a “hold” rating.The current price is $31.72.
Cerence (NASDAQ:CRNC) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. They now have a $6.50 price target on the stock, down previously from $25.00. This represents a 20.4% upside from the current price of $5.40.
Ginkgo Bioworks (NYSE:DNA) was downgraded by analysts at William Blair from a “market perform” rating to an “underperform” rating.The current price is $0.77.
EPAM Systems (NYSE:EPAM) was downgraded by analysts at Scotiabank from a “sector outperform” rating to a “sector perform” rating. They now have a $245.00 price target on the stock, down previously from $300.00. This represents a 30.8% upside from the current price of $187.38.
Evolv Technologies (NASDAQ:EVLV) was downgraded by analysts at Lake Street Capital from a “buy” rating to a “hold” rating. They now have a $3.50 price target on the stock, down previously from $6.00. This represents a 54.2% upside from the current price of $2.27.
Globant (NYSE:GLOB) was downgraded by analysts at Scotiabank from a “sector outperform” rating to a “sector perform” rating. They now have a $200.00 price target on the stock, down previously from $230.00. This represents a 15.1% upside from the current price of $173.77.
Light & Wonder (NASDAQ:LNW) was downgraded by analysts at Susquehanna from a “positive” rating to a “neutral” rating. They now have a $95.00 price target on the stock, down previously from $111.00. This represents a 4.2% upside from the current price of $91.15.
MacroGenics (NASDAQ:MGNX) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating.The current price is $3.57.
MacroGenics (NASDAQ:MGNX) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $7.00 price target on the stock, down previously from $29.00. This represents a 96.1% upside from the current price of $3.57.
MacroGenics (NASDAQ:MGNX) was downgraded by analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating. They now have a $8.00 price target on the stock, down previously from $24.00. This represents a 124.1% upside from the current price of $3.57.
Progyny (NASDAQ:PGNY) was downgraded by analysts at KeyCorp from an “overweight” rating to a “sector weight” rating.The current price is $26.23.
Planet Fitness (NYSE:PLNT) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $70.00 price target on the stock, down previously from $80.00. This represents a 8.7% upside from the current price of $64.39.
PennantPark Investment (NASDAQ:PNNT) was downgraded by analysts at Raymond James from an “outperform” rating to a “market perform” rating.The current price is $7.26.
RAPT Therapeutics (NASDAQ:RAPT) was downgraded by analysts at Barclays PLC from an “overweight” rating to an “equal weight” rating. They now have a $4.00 price target on the stock, down previously from $13.00. This represents a 10.1% downside from the current price of $4.45.
RAPT Therapeutics (NASDAQ:RAPT) was downgraded by analysts at Guggenheim from a “buy” rating to a “neutral” rating.The current price is $4.45.
Ready Capital (NYSE:RC) was downgraded by analysts at LADENBURG THALM/SH SH from a “buy” rating to a “neutral” rating.The current price is $8.35.
Safehold (NYSE:SAFE) was downgraded by analysts at Mizuho from a “buy” rating to a “neutral” rating. They now have a $20.00 price target on the stock, down previously from $22.00. This represents a 3.8% upside from the current price of $19.27.
TELUS International (Cda) (NYSE:TIXT) was downgraded by analysts at Scotiabank from a “sector outperform” rating to a “sector perform” rating. They now have a $10.00 price target on the stock, down previously from $13.00. This represents a 61.3% upside from the current price of $6.20.
Vital Farms (NASDAQ:VITL) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $40.00 price target on the stock, up previously from $30.00. This represents a 8.0% upside from the current price of $37.02.
Vista Outdoor (NYSE:VSTO) was downgraded by analysts at Lake Street Capital from a “buy” rating to a “hold” rating. They now have a $37.00 price target on the stock, up previously from $33.00. This represents a 4.6% upside from the current price of $35.36.
There’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps?
PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE…
This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.
Apogee Therapeutics (NASDAQ:APGE) is now covered by analysts at Bank of America Co.. They set a “buy” rating and a $80.00 price target on the stock. This represents a 55.5% upside from the current price of $51.44.
Aquestive Therapeutics (NASDAQ:AQST) is now covered by analysts at SVB Leerink LLC. They set an “outperform” rating and a $8.00 price target on the stock. This represents a 164.0% upside from the current price of $3.03.
Enfusion (NYSE:ENFN) is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $11.00 price target on the stock. This represents a 20.7% upside from the current price of $9.11.
Ferrari (NYSE:RACE) is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating and a $403.00 price target on the stock. This represents a 0.1% downside from the current price of $403.53.
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Robert W. Baird. They set an “outperform” rating and a $72.00 price target on the stock. This represents a 65.4% upside from the current price of $43.54.
Solventum (NYSE:SOLV) is now covered by analysts at Bank of America Co.. They set a “neutral” rating and a $70.00 price target on the stock. This represents a 9.6% upside from the current price of $63.89.
Sow Good (OTC:SOWG) is now covered by analysts at Roth Mkm. They set a “buy” rating and a $15.00 price target on the stock. This represents a 49.7% upside from the current price of $10.02.
Sow Good (OTC:SOWG) is now covered by analysts at Craig Hallum. They set a “buy” rating and a $20.00 price target on the stock. This represents a 99.6% upside from the current price of $10.02.
Sow Good (OTCMKTS:SOWG) is now covered by analysts at Roth Mkm. They set a “buy” rating and a $15.00 price target on the stock. This represents a 49.7% upside from the current price of $10.02.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeat’s free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that’s you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
